1. Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma. Issue 1 (6th November 2019) Authors: Herrera, Alex F.; Goy, Andre; Mehta, Amitkumar; Ramchandren, Radhakrishnan; Pagel, John M.; Svoboda, Jakub; Guan, Shanhong; Hill, John S.; Kwei, Kevin; Liu, Emily A.; Phillips, Tycel Journal: American journal of hematology Issue: Volume 95:Issue 1(2020:Jan.) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗